Freedom of Information Request – Ref: FOI 132-2025
Thank you for your recent Freedom of Information request. Please find our response below.
You asked:
1. Please provide the total number of patients treated where wound care represented the primary reason for admission, in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25. If available, please provide a breakdown of inpatients compared to outpatients/community visits.
4. What is the average waiting time for an initial wound care assessment in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25?
5. What is the average waiting time for a referral to a specialist tissue viability nurse in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25?
6. Please provide the total number of patients referred from A&E or minor injury/urgent care units to any form of wound care service, in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25. Please provide the total number of A&E and minor injury/urgent care unit admissions in each financial year for comparison.
7. If available, please provide a breakdown of the nature of wounds or conditions most commonly referred to wound care services (e.g. pressure ulcers, leg ulcers, post-operative wounds, diabetic foot ulcers, traumatic wounds).
Please see our response to questions 1, 4, 5, 6 and 7 on the link below:
You asked:
2. Please provide the number of Full-Time Equivalent (FTE) staff delivering wound care services within your organisation, broken down by professional role (e.g. community nurse, tissue viability nurse, podiatrist), in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25.
3. Please provide the number of Tissue Viability Nurses (TVNs) employed by your Trust, in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25.
Please see our response to questions 2 and 3 on the link below:
You asked:
8. Please provide total spend on wound management dressings via Part IXA of the drug tariff (see link below), in the financial years i) 2021-22, ii) 2022-23, iii) 2023-24, iv) 2024-25. https://www.drugtariff.nhsbsa.nhs.uk/#/00726198-DD/DD00726112/Part%20IXA-%20Wound%20Management%20Dressings
Our response:
We do not record or report on information in a way that would enable us to provide a response to this question.
Next steps:
Should you have any queries in relation to our response, please do not hesitate to contact us. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:
Louise Moss
Head of Legal Services / Associate Director of Corporate Governance
c/o Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth, GL3 4AW
E-mail: louise.moss@ghc.nhs.uk
If you are not content with the outcome of any review, you may apply directly to the Information Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.